Daniel S. Chen

Daniel Chen co-authored the seminal cancer-immunity cycle framework that defined the steps of anti-tumor immunity and points of failure in cold tumors. He led clinical development of atezolizumab and has shaped how the field classifies inflamed, excluded, and desert tumor phenotypes. His framework guides cold-to-hot conversion strategies.